rs759440817
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 3P and 5B. BS3PM2PP4BP4
This summary comes from the ClinGen Evidence Repository: The NM_000527.5(LDLR):c.2291T>C (p.Ile764Thr) variant is classified as Likely Benign for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2, PP4, BP4 and BS3 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on February 28, 2025.The supporting evidence is as follows: PM2: PopMax MAF = 0.0001337 (0.01337%) in East Asian exomes + genomes (gnomAD v4.1.0).PP4: Variant meets PM2 and is identified in at least 1 index case who fulfills Simon Broome criteria for possible FH from Cardiovascular Research Group, Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal, after alternative causes of high cholesterol were excluded.BP4: REVEL = 0.352, it is below 0.50, so splicing evaluation required. Functional data on splicing not available. A) Variant not on limits.B) Does not create GT.C) There is a GT nearby. MES scores: variant cryptic = -5.73, wt cryptic = -8.16, canonical donor site = 9.06. Cryptic scores are negative, splice site not used. Variant is not predicted to alter splicing. BS3: Level 1 assay: PMID 34167030 (Alves et al., 2021): Heterologous cells (CHO), FACS; Result - > Normal cell surface LDLR (105%), LDL-LDLR binding (90%) and uptake (89%). Functional study is consistent with no damaging effect.Level 3 assay: PMID 37719435 (Graça et al., 2023): Heterologous cells (CHO), microscopy assays; Result - >100% LDLR expression and >100% LDLR activity. Functional study is consistent with no damaging effect.With the application of BP4 and BS3 and the functional evidence available, consensus was to classify this variant as Likely Benign. LINK:https://erepo.genome.network/evrepo/ui/classification/CA039387/MONDO:0007750/013
Frequency
Consequence
NM_000527.5 missense
Scores
Clinical Significance
Conservation
Publications
- hypercholesterolemia, familial, 1Inheritance: AD, SD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, ClinGen
- homozygous familial hypercholesterolemiaInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000527.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | NM_000527.5 | MANE Select | c.2291T>C | p.Ile764Thr | missense | Exon 15 of 18 | NP_000518.1 | ||
| LDLR | NM_001195798.2 | c.2291T>C | p.Ile764Thr | missense | Exon 15 of 18 | NP_001182727.1 | |||
| LDLR | NM_001195799.2 | c.2168T>C | p.Ile723Thr | missense | Exon 14 of 17 | NP_001182728.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| LDLR | ENST00000558518.6 | TSL:1 MANE Select | c.2291T>C | p.Ile764Thr | missense | Exon 15 of 18 | ENSP00000454071.1 | ||
| LDLR | ENST00000252444.10 | TSL:1 | c.2549T>C | p.Ile850Thr | missense | Exon 15 of 18 | ENSP00000252444.6 | ||
| LDLR | ENST00000558013.5 | TSL:1 | c.2291T>C | p.Ile764Thr | missense | Exon 15 of 18 | ENSP00000453346.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000398 AC: 10AN: 251168 AF XY: 0.0000515 show subpopulations
GnomAD4 exome AF: 0.0000109 AC: 16AN: 1461830Hom.: 0 Cov.: 34 AF XY: 0.0000138 AC XY: 10AN XY: 727212 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152150Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74320 show subpopulations
ClinVar
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at